|Filed Under:||Medical / Pharmaceutical|
|Posts on Regator:||143|
|Posts / Week:||1.1|
|Archived Since:||November 22, 2010|
The Times is discontinuing the Prescriptions blog.
A new study finds that primary care doctors are referring patients to other doctors at double the rate of a decade ago. The reasons are unclear but the researchers say the practice is driving up health care costs.
A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.
Walgreen to introduce a national plan it hopes will minimize customer disruption from its contract battle with its pharmacy benefits manager, Express Scripts.
The industry did not get an exemption for brokers' fees under the regulations for how much of a customer's premium must be spent on medical care.
The federal agency says it wants more authority to crack down on insurance plans that take advantage of small businesses and their employees.
Health Affairs offers a retrospective on Dr. Donald Berwick, who is leaving his post as head of the Centers for Medicare and Medicaid Services.
The Department of Health and Human Services issued the funds as part of the planning to set up exchanges for health insurance coverage.
The Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for breast cancer after concluding that it "has not been shown to be safe and effective for that use."
Moving to protect a lucrative monopoly against impending competition, Amgen has reached an agreement that will preserve its status as the main supplier of anemia drugs to one of the nation's two large kidney dialysis chains.
Articles in a medical journal say the Food and Drug Administration needs to offer doctors and consumers more guidance about potentially dangerous prescriptions.
Wal-Mart has sent letters seeking new partnerships with medical providers, in an effort to catch up to some of its competitors' retail health clinics.
Use of the database now requires a promise that individual doctors would not be identified through matching the information with other publicly available files.
The smaller company objected to Eli Lilly's work with what it considered a competing diabetes drug.
Regulations related to accountable care organizations include fewer benchmarks and provide upfront incentives for some groups.
The Food and Drug Administration will allow the device to be used by dermatologists in the hopes of detecting the skin cancer early.
Medivation announced that a late-stage clinical trial was so successful that it was stopped early to provide the drug to all participants.
About 10 percent of the nation's hospitals meet criteria that would enable them to qualify for extra payments under Medicare and Medicaid.
The new treatments were approved only last spring.
A new Denmark study shows that a newer generation of birth control pills poses more danger of venous thromboembolism.